Annual EBITDA
$262.10 M
+$12.76 M+5.12%
31 March 2024
Summary:
Haemonetics annual earnings before interest, taxes, depreciation & amortization is currently $262.10 million, with the most recent change of +$12.76 million (+5.12%) on 31 March 2024. During the last 3 years, it has risen by +$88.06 million (+50.60%). HAE annual EBITDA is now at all-time high.HAE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$80.91 M
+$12.02 M+17.45%
28 September 2024
Summary:
Haemonetics quarterly earnings before interest, taxes, depreciation & amortization is currently $80.91 million, with the most recent change of +$12.02 million (+17.45%) on 28 September 2024. Over the past year, it has increased by +$22.60 million (+38.75%). HAE quarterly EBITDA is now at all-time high.HAE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$276.90 M
+$22.60 M+8.89%
28 September 2024
Summary:
Haemonetics TTM earnings before interest, taxes, depreciation & amortization is currently $276.90 million, with the most recent change of +$22.60 million (+8.89%) on 28 September 2024. Over the past year, it has increased by +$15.93 million (+6.11%). HAE TTM EBITDA is now at all-time high.HAE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.1% | +38.8% | +6.1% |
3 y3 years | +50.6% | +34.8% | +104.8% |
5 y5 years | +35.8% | +5.4% | +37.9% |
HAE EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +50.6% | at high | +83.8% | at high | +104.8% |
5 y | 5 years | at high | +50.6% | at high | >+9999.0% | at high | +104.8% |
alltime | all time | at high | +610.3% | at high | +310.4% | at high | +696.3% |
Haemonetics EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $80.91 M(+17.5%) | $276.90 M(+8.9%) |
June 2024 | - | $68.89 M(+19.6%) | $254.30 M(-3.0%) |
Mar 2024 | $262.10 M(+5.1%) | - | - |
Mar 2024 | - | $57.58 M(-17.2%) | $262.10 M(-0.6%) |
Dec 2023 | - | $69.51 M(+19.2%) | $263.63 M(+1.0%) |
Sept 2023 | - | $58.32 M(-24.0%) | $260.96 M(-4.3%) |
June 2023 | - | $76.69 M(+29.7%) | $272.82 M(+9.4%) |
Mar 2023 | $249.34 M(+39.7%) | $59.11 M(-11.6%) | $249.34 M(+6.4%) |
Dec 2022 | - | $66.85 M(-4.7%) | $234.24 M(+3.0%) |
Sept 2022 | - | $70.17 M(+31.9%) | $227.41 M(+10.8%) |
June 2022 | - | $53.21 M(+20.9%) | $205.29 M(+15.0%) |
Mar 2022 | $178.50 M(+2.6%) | $44.01 M(-26.7%) | $178.50 M(+32.0%) |
Dec 2021 | - | $60.02 M(+24.9%) | $135.22 M(-0.9%) |
Sept 2021 | - | $48.04 M(+81.8%) | $136.40 M(-18.8%) |
June 2021 | - | $26.42 M(+3495.0%) | $168.02 M(-3.5%) |
Mar 2021 | $174.03 M(-18.5%) | $735.00 K(-98.8%) | $174.03 M(-23.7%) |
Dec 2020 | - | $61.20 M(-23.2%) | $228.07 M(-2.9%) |
Sept 2020 | - | $79.66 M(+145.6%) | $234.83 M(+1.2%) |
June 2020 | - | $32.44 M(-40.8%) | $231.94 M(+8.6%) |
Mar 2020 | $213.64 M(+10.7%) | $54.77 M(-19.4%) | $213.64 M(+0.5%) |
Dec 2019 | - | $67.96 M(-11.5%) | $212.50 M(+5.8%) |
Sept 2019 | - | $76.77 M(+443.1%) | $200.81 M(+14.5%) |
June 2019 | - | $14.13 M(-73.6%) | $175.39 M(-9.1%) |
Mar 2019 | $192.96 M(+25.8%) | $53.64 M(-4.7%) | $192.96 M(+9.3%) |
Dec 2018 | - | $56.27 M(+9.6%) | $176.58 M(+23.0%) |
Sept 2018 | - | $51.35 M(+62.0%) | $143.61 M(+3.5%) |
June 2018 | - | $31.71 M(-14.9%) | $138.71 M(-9.6%) |
Mar 2018 | $153.40 M(+118.1%) | $37.26 M(+59.9%) | $153.40 M(+89.8%) |
Dec 2017 | - | $23.29 M(-49.9%) | $80.84 M(-20.0%) |
Sept 2017 | - | $46.45 M(+0.1%) | $101.04 M(-1.0%) |
June 2017 | - | $46.40 M(-231.4%) | $102.09 M(+45.1%) |
Mar 2017 | $70.35 M(+53.0%) | -$35.30 M(-181.2%) | $70.35 M(-42.5%) |
Dec 2016 | - | $43.49 M(-8.4%) | $122.30 M(+203.1%) |
Sept 2016 | - | $47.50 M(+224.0%) | $40.35 M(+16.1%) |
June 2016 | - | $14.66 M(-11.9%) | $34.77 M(-24.4%) |
Mar 2016 | $45.97 M(-64.4%) | $16.64 M(-143.3%) | $45.97 M(-29.9%) |
Dec 2015 | - | -$38.45 M(-191.7%) | $65.55 M(-54.6%) |
Sept 2015 | - | $41.92 M(+62.1%) | $144.53 M(+6.2%) |
June 2015 | - | $25.86 M(-28.6%) | $136.13 M(+5.4%) |
Mar 2015 | $129.12 M(-0.6%) | $36.22 M(-10.6%) | $129.12 M(+0.0%) |
Dec 2014 | - | $40.53 M(+20.9%) | $129.08 M(+1.5%) |
Sept 2014 | - | $33.52 M(+77.9%) | $127.22 M(-7.2%) |
June 2014 | - | $18.84 M(-47.9%) | $137.03 M(+5.5%) |
Mar 2014 | $129.93 M(+3.0%) | $36.18 M(-6.4%) | $129.93 M(-3.4%) |
Dec 2013 | - | $38.67 M(-10.8%) | $134.44 M(+3.7%) |
Sept 2013 | - | $43.33 M(+268.8%) | $129.65 M(+14.1%) |
June 2013 | - | $11.75 M(-71.1%) | $113.65 M(-9.9%) |
Mar 2013 | $126.17 M(-8.0%) | $40.70 M(+20.1%) | $126.16 M(+5.9%) |
Dec 2012 | - | $33.88 M(+24.0%) | $119.14 M(-3.3%) |
Sept 2012 | - | $27.33 M(+12.7%) | $123.22 M(-3.0%) |
June 2012 | - | $24.26 M(-28.0%) | $127.09 M(-8.4%) |
Mar 2012 | $137.14 M(-12.5%) | $33.67 M(-11.3%) | $138.72 M(-3.1%) |
Dec 2011 | - | $37.96 M(+21.7%) | $143.17 M(-2.0%) |
Sept 2011 | - | $31.20 M(-13.1%) | $146.11 M(-6.4%) |
June 2011 | - | $35.90 M(-5.8%) | $156.10 M(-0.7%) |
Mar 2011 | $156.80 M(+25.2%) | $38.12 M(-6.8%) | $157.14 M(+16.9%) |
Dec 2010 | - | $40.89 M(-0.7%) | $134.38 M(+3.2%) |
Sept 2010 | - | $41.19 M(+11.5%) | $130.19 M(+3.3%) |
June 2010 | - | $36.94 M(+140.4%) | $125.97 M(+0.6%) |
Mar 2010 | $125.25 M(+3.1%) | $15.36 M(-58.1%) | $125.24 M(-7.1%) |
Dec 2009 | - | $36.71 M(-0.7%) | $134.88 M(+1.1%) |
Sept 2009 | - | $36.97 M(+2.1%) | $133.44 M(+2.5%) |
June 2009 | - | $36.21 M(+44.9%) | $130.18 M(+7.3%) |
Mar 2009 | $121.53 M(+19.8%) | $25.00 M(-29.1%) | $121.29 M(-3.3%) |
Dec 2008 | - | $35.27 M(+4.6%) | $125.39 M(+6.8%) |
Sept 2008 | - | $33.71 M(+23.4%) | $117.43 M(+10.9%) |
June 2008 | - | $27.32 M(-6.1%) | $105.85 M(+4.3%) |
Mar 2008 | $101.48 M | $29.10 M(+6.5%) | $101.49 M(-2.7%) |
Dec 2007 | - | $27.31 M(+23.5%) | $104.34 M(+3.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2007 | - | $22.12 M(-3.6%) | $100.94 M(+0.4%) |
June 2007 | - | $22.96 M(-28.1%) | $100.50 M(+1.0%) |
Mar 2007 | $99.32 M(-20.0%) | $31.95 M(+33.6%) | $99.47 M(+1.5%) |
Dec 2006 | - | $23.91 M(+10.3%) | $98.03 M(-19.4%) |
Sept 2006 | - | $21.68 M(-1.2%) | $121.63 M(-0.5%) |
June 2006 | - | $21.94 M(-28.1%) | $122.28 M(-1.5%) |
Mar 2006 | $124.17 M(+41.9%) | $30.50 M(-35.8%) | $124.17 M(+6.8%) |
Dec 2005 | - | $47.51 M(+112.7%) | $116.29 M(+28.5%) |
Sept 2005 | - | $22.33 M(-6.3%) | $90.48 M(+1.4%) |
June 2005 | - | $23.83 M(+5.3%) | $89.22 M(+1.9%) |
Mar 2005 | $87.52 M(+13.0%) | $22.62 M(+4.3%) | $87.52 M(-0.5%) |
Dec 2004 | - | $21.70 M(+2.9%) | $87.96 M(+0.0%) |
Sept 2004 | - | $21.08 M(-4.7%) | $87.95 M(+4.7%) |
June 2004 | - | $22.12 M(-4.1%) | $84.02 M(+8.2%) |
Mar 2004 | $77.44 M(+17.5%) | $23.06 M(+6.4%) | $77.67 M(+15.9%) |
Dec 2003 | - | $21.68 M(+26.4%) | $67.01 M(+3.0%) |
Sept 2003 | - | $17.15 M(+8.8%) | $65.06 M(+0.2%) |
June 2003 | - | $15.77 M(+27.2%) | $64.92 M(-1.5%) |
Mar 2003 | $65.91 M(-8.5%) | $12.40 M(-37.2%) | $65.91 M(-18.7%) |
Dec 2002 | - | $19.74 M(+16.0%) | $81.06 M(+19.4%) |
Sept 2002 | - | $17.02 M(+1.5%) | $67.86 M(-7.6%) |
June 2002 | - | $16.76 M(-39.2%) | $73.45 M(-17.8%) |
Mar 2002 | $72.06 M(-11.1%) | $27.55 M(+320.9%) | $89.30 M(-8.1%) |
Dec 2001 | - | $6.54 M(-71.0%) | $97.13 M(-9.7%) |
Sept 2001 | - | $22.60 M(-30.7%) | $107.59 M(+8.4%) |
June 2001 | - | $32.61 M(-7.8%) | $99.21 M(+22.6%) |
Mar 2001 | $81.02 M(+10.8%) | $35.37 M(+108.1%) | $80.92 M(+11.7%) |
Dec 2000 | - | $17.00 M(+19.5%) | $72.47 M(+3.9%) |
Sept 2000 | - | $14.23 M(-0.6%) | $69.77 M(-2.6%) |
June 2000 | - | $14.31 M(-46.8%) | $71.64 M(-2.2%) |
Mar 2000 | $73.13 M(-9.5%) | $26.93 M(+88.3%) | $73.23 M(-12.9%) |
Dec 1999 | - | $14.30 M(-11.2%) | $84.06 M(-0.1%) |
Sept 1999 | - | $16.10 M(+1.3%) | $84.16 M(-1.3%) |
June 1999 | - | $15.90 M(-57.9%) | $85.26 M(+4.3%) |
Mar 1999 | $80.76 M(+49.8%) | $37.76 M(+162.2%) | $81.76 M(+59.1%) |
Dec 1998 | - | $14.40 M(-16.3%) | $51.40 M(-0.4%) |
Sept 1998 | - | $17.20 M(+38.7%) | $51.60 M(+4.2%) |
June 1998 | - | $12.40 M(+67.6%) | $49.50 M(-4.8%) |
Mar 1998 | $53.90 M(-25.1%) | $7.40 M(-49.3%) | $52.00 M(-24.4%) |
Dec 1997 | - | $14.60 M(-3.3%) | $68.80 M(+0.1%) |
Sept 1997 | - | $15.10 M(+1.3%) | $68.70 M(-2.1%) |
June 1997 | - | $14.90 M(-38.4%) | $70.20 M(-3.4%) |
Mar 1997 | $72.00 M(+6.8%) | $24.20 M(+66.9%) | $72.70 M(+16.9%) |
Dec 1996 | - | $14.50 M(-12.7%) | $62.20 M(-5.5%) |
Sept 1996 | - | $16.60 M(-4.6%) | $65.80 M(-1.9%) |
June 1996 | - | $17.40 M(+27.0%) | $67.10 M(-0.4%) |
Mar 1996 | $67.40 M(+2.0%) | $13.70 M(-24.3%) | $67.40 M(-3.2%) |
Dec 1995 | - | $18.10 M(+1.1%) | $69.60 M(+2.1%) |
Sept 1995 | - | $17.90 M(+1.1%) | $68.20 M(+0.7%) |
June 1995 | - | $17.70 M(+11.3%) | $67.70 M(+2.1%) |
Mar 1995 | $66.10 M(+5.8%) | $15.90 M(-4.8%) | $66.30 M(-0.5%) |
Dec 1994 | - | $16.70 M(-4.0%) | $66.60 M(+0.3%) |
Sept 1994 | - | $17.40 M(+6.7%) | $66.40 M(+2.0%) |
June 1994 | - | $16.30 M(+0.6%) | $65.10 M(+4.0%) |
Mar 1994 | $62.50 M(+24.3%) | $16.20 M(-1.8%) | $62.60 M(+4.7%) |
Dec 1993 | - | $16.50 M(+2.5%) | $59.80 M(+5.1%) |
Sept 1993 | - | $16.10 M(+16.7%) | $56.90 M(+6.8%) |
June 1993 | - | $13.80 M(+3.0%) | $53.30 M(+5.5%) |
Mar 1993 | $50.30 M(+36.3%) | $13.40 M(-1.5%) | $50.50 M(+6.1%) |
Dec 1992 | - | $13.60 M(+8.8%) | $47.60 M(+9.2%) |
Sept 1992 | - | $12.50 M(+13.6%) | $43.60 M(+9.0%) |
June 1992 | - | $11.00 M(+4.8%) | $40.00 M(+8.7%) |
Mar 1992 | $36.90 M(-76.5%) | $10.50 M(+9.4%) | $36.80 M(-44.0%) |
Dec 1991 | - | $9.60 M(+7.9%) | $65.70 M(-31.1%) |
Sept 1991 | - | $8.90 M(+14.1%) | $95.40 M(-24.2%) |
June 1991 | - | $7.80 M(-80.2%) | $125.80 M(-20.0%) |
Mar 1991 | $157.30 M | $39.40 M(+0.3%) | $157.30 M(+33.4%) |
Dec 1990 | - | $39.30 M(0.0%) | $117.90 M(+50.0%) |
Sept 1990 | - | $39.30 M(0.0%) | $78.60 M(+100.0%) |
June 1990 | - | $39.30 M | $39.30 M |
FAQ
- What is Haemonetics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Haemonetics?
- What is Haemonetics annual EBITDA year-on-year change?
- What is Haemonetics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Haemonetics?
- What is Haemonetics quarterly EBITDA year-on-year change?
- What is Haemonetics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Haemonetics?
- What is Haemonetics TTM EBITDA year-on-year change?
What is Haemonetics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HAE is $262.10 M
What is the all time high annual EBITDA for Haemonetics?
Haemonetics all-time high annual earnings before interest, taxes, depreciation & amortization is $262.10 M
What is Haemonetics annual EBITDA year-on-year change?
Over the past year, HAE annual earnings before interest, taxes, depreciation & amortization has changed by +$12.76 M (+5.12%)
What is Haemonetics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HAE is $80.91 M
What is the all time high quarterly EBITDA for Haemonetics?
Haemonetics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $80.91 M
What is Haemonetics quarterly EBITDA year-on-year change?
Over the past year, HAE quarterly earnings before interest, taxes, depreciation & amortization has changed by +$22.60 M (+38.75%)
What is Haemonetics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HAE is $276.90 M
What is the all time high TTM EBITDA for Haemonetics?
Haemonetics all-time high TTM earnings before interest, taxes, depreciation & amortization is $276.90 M
What is Haemonetics TTM EBITDA year-on-year change?
Over the past year, HAE TTM earnings before interest, taxes, depreciation & amortization has changed by +$15.93 M (+6.11%)